Logo image of ADYEN.AS

ADYEN NV (ADYEN.AS) Stock Fundamental Analysis

AMS:ADYEN - Euronext Amsterdam - NL0012969182 - Common Stock - Currency: EUR

1466.4  -2 (-0.14%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ADYEN. ADYEN was compared to 51 industry peers in the Financial Services industry. ADYEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, ADYEN is valued expensive at the moment. These ratings could make ADYEN a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

ADYEN had positive earnings in the past year.
In the past year ADYEN had a positive cash flow from operations.
In the past 5 years ADYEN has always been profitable.
Each year in the past 5 years ADYEN had a positive operating cash flow.
ADYEN.AS Yearly Net Income VS EBIT VS OCF VS FCFADYEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

ADYEN's Return On Assets of 8.10% is fine compared to the rest of the industry. ADYEN outperforms 78.43% of its industry peers.
Looking at the Return On Equity, with a value of 21.86%, ADYEN is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
ADYEN's Return On Invested Capital of 15.06% is amongst the best of the industry. ADYEN outperforms 88.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADYEN is significantly above the industry average of 10.89%.
Industry RankSector Rank
ROA 8.1%
ROE 21.86%
ROIC 15.06%
ROA(3y)7.6%
ROA(5y)7.44%
ROE(3y)22.46%
ROE(5y)22.95%
ROIC(3y)16.46%
ROIC(5y)18.16%
ADYEN.AS Yearly ROA, ROE, ROICADYEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ADYEN has a Profit Margin of 41.07%. This is amongst the best in the industry. ADYEN outperforms 84.31% of its industry peers.
ADYEN's Profit Margin has improved in the last couple of years.
ADYEN's Operating Margin of 39.41% is amongst the best of the industry. ADYEN outperforms 82.35% of its industry peers.
In the last couple of years the Operating Margin of ADYEN has grown nicely.
ADYEN has a Gross Margin of 88.61%. This is amongst the best in the industry. ADYEN outperforms 90.20% of its industry peers.
In the last couple of years the Gross Margin of ADYEN has grown nicely.
Industry RankSector Rank
OM 39.41%
PM (TTM) 41.07%
GM 88.61%
OM growth 3Y58.95%
OM growth 5Y29.15%
PM growth 3Y73.71%
PM growth 5Y36.03%
GM growth 3Y74.4%
GM growth 5Y34.53%
ADYEN.AS Yearly Profit, Operating, Gross MarginsADYEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

ADYEN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ADYEN has been increased compared to 1 year ago.
The number of shares outstanding for ADYEN has been increased compared to 5 years ago.
ADYEN has a better debt/assets ratio than last year.
ADYEN.AS Yearly Shares OutstandingADYEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ADYEN.AS Yearly Total Debt VS Total AssetsADYEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.16 indicates that ADYEN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.16, ADYEN belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
The Debt to FCF ratio of ADYEN is 0.14, which is an excellent value as it means it would take ADYEN, only 0.14 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.14, ADYEN belongs to the best of the industry, outperforming 96.08% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that ADYEN is not too dependend on debt financing.
ADYEN has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. ADYEN outperforms 86.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.14
Altman-Z 5.16
ROIC/WACC1.99
WACC7.58%
ADYEN.AS Yearly LT Debt VS Equity VS FCFADYEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

ADYEN has a Current Ratio of 1.55. This is a normal value and indicates that ADYEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, ADYEN is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
ADYEN has a Quick Ratio of 1.54. This is a normal value and indicates that ADYEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.54, ADYEN is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
ADYEN.AS Yearly Current Assets VS Current LiabilitesADYEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

6

3. Growth

3.1 Past

ADYEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.14%, which is quite impressive.
The Earnings Per Share has been growing by 34.72% on average over the past years. This is a very strong growth
Looking at the last year, ADYEN shows a very strong growth in Revenue. The Revenue has grown by 20.89%.
Measured over the past years, ADYEN shows a decrease in Revenue. The Revenue has been decreasing by -3.25% on average per year.
EPS 1Y (TTM)32.14%
EPS 3Y24.61%
EPS 5Y34.72%
EPS Q2Q%23.43%
Revenue 1Y (TTM)20.89%
Revenue growth 3Y-27.84%
Revenue growth 5Y-3.25%
Sales Q2Q%22.07%

3.2 Future

The Earnings Per Share is expected to grow by 19.45% on average over the next years. This is quite good.
ADYEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.92% yearly.
EPS Next Y26.6%
EPS Next 2Y26.24%
EPS Next 3Y26.57%
EPS Next 5Y19.45%
Revenue Next Year25.92%
Revenue Next 2Y25.89%
Revenue Next 3Y24.7%
Revenue Next 5Y19.92%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ADYEN.AS Yearly Revenue VS EstimatesADYEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
ADYEN.AS Yearly EPS VS EstimatesADYEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20 40 60 80

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.47 indicates a quite expensive valuation of ADYEN.
74.51% of the companies in the same industry are cheaper than ADYEN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ADYEN to the average of the S&P500 Index (28.79), we can say ADYEN is valued expensively.
A Price/Forward Earnings ratio of 39.08 indicates a quite expensive valuation of ADYEN.
ADYEN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ADYEN is more expensive than 66.67% of the companies in the same industry.
ADYEN is valuated expensively when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 49.47
Fwd PE 39.08
ADYEN.AS Price Earnings VS Forward Price EarningsADYEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADYEN is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADYEN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.8
EV/EBITDA 36.85
ADYEN.AS Per share dataADYEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ADYEN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ADYEN may justify a higher PE ratio.
A more expensive valuation may be justified as ADYEN's earnings are expected to grow with 26.57% in the coming years.
PEG (NY)1.86
PEG (5Y)1.43
EPS Next 2Y26.24%
EPS Next 3Y26.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ADYEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADYEN NV

AMS:ADYEN (4/25/2025, 7:00:00 PM)

1466.4

-2 (-0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)08-13 2025-08-13
Inst Owners78.71%
Inst Owner ChangeN/A
Ins Owners7.35%
Ins Owner ChangeN/A
Market Cap46.18B
Analysts79.05
Price Target1934.57 (31.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.25%
PT rev (3m)18.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.92%
EPS NY rev (3m)1.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 49.47
Fwd PE 39.08
P/S 20.5
P/FCF 28.8
P/OCF 27.09
P/B 10.91
P/tB 10.93
EV/EBITDA 36.85
EPS(TTM)29.64
EY2.02%
EPS(NY)37.52
Fwd EY2.56%
FCF(TTM)50.92
FCFY3.47%
OCF(TTM)54.14
OCFY3.69%
SpS71.54
BVpS134.38
TBVpS134.11
PEG (NY)1.86
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 8.1%
ROE 21.86%
ROCE 20.14%
ROIC 15.06%
ROICexc N/A
ROICexgc N/A
OM 39.41%
PM (TTM) 41.07%
GM 88.61%
FCFM 71.18%
ROA(3y)7.6%
ROA(5y)7.44%
ROE(3y)22.46%
ROE(5y)22.95%
ROIC(3y)16.46%
ROIC(5y)18.16%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.02%
ROCE(5y)24.3%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y58.95%
OM growth 5Y29.15%
PM growth 3Y73.71%
PM growth 5Y36.03%
GM growth 3Y74.4%
GM growth 5Y34.53%
F-Score8
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.14
Debt/EBITDA 0.17
Cap/Depr 96.92%
Cap/Sales 4.49%
Interest Coverage 33.2
Cash Conversion 171.8%
Profit Quality 173.32%
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 5.16
F-Score8
WACC7.58%
ROIC/WACC1.99
Cap/Depr(3y)111.44%
Cap/Depr(5y)113.24%
Cap/Sales(3y)3.12%
Cap/Sales(5y)2.17%
Profit Quality(3y)257.28%
Profit Quality(5y)305.77%
High Growth Momentum
Growth
EPS 1Y (TTM)32.14%
EPS 3Y24.61%
EPS 5Y34.72%
EPS Q2Q%23.43%
EPS Next Y26.6%
EPS Next 2Y26.24%
EPS Next 3Y26.57%
EPS Next 5Y19.45%
Revenue 1Y (TTM)20.89%
Revenue growth 3Y-27.84%
Revenue growth 5Y-3.25%
Sales Q2Q%22.07%
Revenue Next Year25.92%
Revenue Next 2Y25.89%
Revenue Next 3Y24.7%
Revenue Next 5Y19.92%
EBIT growth 1Y35.02%
EBIT growth 3Y14.7%
EBIT growth 5Y24.96%
EBIT Next Year46.81%
EBIT Next 3Y35.56%
EBIT Next 5Y26.7%
FCF growth 1Y-10.93%
FCF growth 3Y-3.16%
FCF growth 5Y25.77%
OCF growth 1Y-8.84%
OCF growth 3Y-2.16%
OCF growth 5Y26.35%